TETRACUMIN Trademark

Trademark Overview


On Friday, June 23, 2017, a trademark application was filed for TETRACUMIN with the United States Patent and Trademark Office. The USPTO has given the TETRACUMIN trademark a serial number of 87503676. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, May 27, 2025. This trademark is owned by Tesseract Medical Research, LLC. The TETRACUMIN trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing curcumin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of anti-inflammatories for increasing curcumin in the body for the treatment of exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain; functional nutrient preparations containing curcumin to mitigate exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle ...
tetracumin

General Information


Serial Number87503676
Word MarkTETRACUMIN
Filing DateFriday, June 23, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, May 27, 2025
Registration Number5602395
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements


Goods and ServicesDietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing curcumin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of anti-inflammatories for increasing curcumin in the body for the treatment of exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain; functional nutrient preparations containing curcumin to mitigate exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with curcumin, namely, exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain
Pseudo MarkTETRA CUMIN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code005
First Use Anywhere DateMonday, May 7, 2018
First Use In Commerce DateMonday, May 7, 2018

Trademark Owner History


Party NameTesseract Medical Research, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Party NameTesseract Medical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Party NameTesseract Medical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Trademark Events


Event DateEvent Description
Thursday, September 28, 2017NON-FINAL ACTION WRITTEN
Friday, March 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 27, 2017NEW APPLICATION ENTERED
Friday, June 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 21, 2017ASSIGNED TO EXAMINER
Thursday, September 28, 2017NON-FINAL ACTION E-MAILED
Thursday, September 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 21, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, March 21, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 21, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Friday, March 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 21, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 3, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 29, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, August 29, 2018USE AMENDMENT FILED
Saturday, September 22, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 27, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 2, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, May 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 7, 2025POST REGISTRATION ACTION MAILED - SEC. 8
Monday, May 12, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, May 27, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, May 27, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, December 9, 2024TEAS SECTION 8 RECEIVED